Track topics on Twitter Track topics that are important to you
European regulators have granted FEops CE mark approval for its HEARTguide system, which is intended for planning structural -More-
FEops, a leader in personalized predictive planning for structural heart interventions, today announced that FEops HEARTguideTM has received CE mark approval. FEops ...
FEops, a leader in personalized predictive planning for structural heart interventions, is proud to announce that FEops HEARTguideTM was the winning entry at CSI Frankfurt 2019 voted on by physician ...
Percutaneous left atrial appendage (LAA) closure can be optimised through diligent preprocedural planning. Cardiac computational tomography (CCT) is increasingly recognised as a valuable tool in this ...
Privately held FEops, headquartered in Gent, Belgium, is a leader in personalized predictive planning for structural heart interventions. In September 2017, FEops announced that i...
We have published hundreds of FEops news stories on BioPortfolio along with dozens of FEops Clinical Trials and PubMed Articles about FEops for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of FEops Companies in our database. You can also find out about relevant FEops Drugs and Medications on this site too.